Free Trial

Eurofins Scient (OTCMKTS:ERFSF) Shares Gap Up - Here's What Happened

Eurofins Scient logo with Medical background

Key Points

  • Eurofins Scient shares experienced a significant increase, gapping up from a previous close of $69.27 to open at $74.16.
  • Analysts have given Eurofins Scient an average rating of "Hold," with one analyst issuing a Strong Buy rating.
  • The company has a debt-to-equity ratio of 0.77 and a current ratio of 1.26, indicating its financial health.
  • MarketBeat previews the top five stocks to own by November 1st.

Eurofins Scient (OTCMKTS:ERFSF - Get Free Report) shares gapped up prior to trading on Wednesday . The stock had previously closed at $69.27, but opened at $74.16. Eurofins Scient shares last traded at $74.16, with a volume of 57 shares traded.

Analysts Set New Price Targets

Separately, Citigroup reissued a "neutral" rating on shares of Eurofins Scient in a research note on Friday, July 25th. One analyst has rated the stock with a Strong Buy rating and five have issued a Hold rating to the company. According to data from MarketBeat.com, Eurofins Scient presently has an average rating of "Hold".

Check Out Our Latest Analysis on Eurofins Scient

Eurofins Scient Price Performance

The stock has a fifty day simple moving average of $75.02 and a 200-day simple moving average of $69.88. The company has a debt-to-equity ratio of 0.77, a quick ratio of 1.19 and a current ratio of 1.26.

About Eurofins Scient

(Get Free Report)

Eurofins Scientific SE, together with its subsidiaries, provides various analytical testing and laboratory services worldwide. The company offers a portfolio of various analytical methods and tests to evaluate the safety, identity, composition, authenticity, origin, traceability, and purity of various products.

Featured Stories

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.

Should You Invest $1,000 in Eurofins Scient Right Now?

Before you consider Eurofins Scient, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Eurofins Scient wasn't on the list.

While Eurofins Scient currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

Elon Musk's Next Move Cover

Explore Elon Musk’s boldest ventures yet—from AI and autonomy to space colonization—and find out how investors can ride the next wave of innovation.

Get This Free Report
Like this article? Share it with a colleague.